Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat. - Rahaghi, Franck F.; Balasubramanian, Vijay P.; Bourge, Robert C.; Burger, Charles D.; Chakinala, Murali M.; Eggert, Michael S.; Elwing, Jean M.; Feldman, Jeremy; King, Christopher; Klinger, James R.; Mathai, Stephen C.; McConnell, John Wesley; et al. (Pulmonary Circulation, 2022)